Literature DB >> 10079180

Epithelin/granulin growth factors: extracellular cofactors for HIV-1 and HIV-2 Tat proteins.

D P Trinh1, K M Brown, K T Jeang.   

Abstract

Epithelin/granulin growth factor is synthesized as a 593 amino acid precursor protein that contains 7.5 imperfectly conserved repeats of approximately 57 amino acids. Processed epithelin/granulin peptides have been isolated from vertebrate/invertebrate species and are growth factors implicated in epithelial and haemic cell function. Here they are identified as Human Immunodeficiency Virus (HIV) Tat binding proteins using the yeast two-hybrid assay. Intracellularly in yeast, mutation of selected cysteines in an epithelin/granulin dimeric repeat caused loss of binding to Tat exon 1. In vitro binding of HIV-1 and HIV-2 Tat to epithelin/granulin dimeric and monomeric repeats was also observed by GST-glutathione bead "pulldown" assays. Because Tat is actively secreted from HIV-infected cells and has been shown to serve as a mitogenic factor for angiogenesis and for Kaposi-like cells, our observations suggest that epithelin/granulin growth factors may function as biologically important extracellular Tat co-factors. Copyright 1999 Academic Press.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10079180     DOI: 10.1006/bbrc.1999.0317

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  12 in total

1.  Selective CXCR4 antagonism by Tat: implications for in vivo expansion of coreceptor use by HIV-1.

Authors:  H Xiao; C Neuveut; H L Tiffany; M Benkirane; E A Rich; P M Murphy; K T Jeang
Journal:  Proc Natl Acad Sci U S A       Date:  2000-10-10       Impact factor: 11.205

Review 2.  Potential roles of microglial cell progranulin in HIV-associated CNS pathologies and neurocognitive impairment.

Authors:  Hyeon-Sook Suh; Benjamin B Gelman; Sunhee C Lee
Journal:  J Neuroimmune Pharmacol       Date:  2014-03       Impact factor: 4.147

Review 3.  Cellular effects of progranulin in health and disease.

Authors:  Louis De Muynck; Philip Van Damme
Journal:  J Mol Neurosci       Date:  2011-05-25       Impact factor: 3.444

Review 4.  Progranulin: A conductor of receptors orchestra, a chaperone of lysosomal enzymes and a therapeutic target for multiple diseases.

Authors:  Yazhou Cui; Aubryanna Hettinghouse; Chuan-Ju Liu
Journal:  Cytokine Growth Factor Rev       Date:  2019-01-30       Impact factor: 7.638

5.  The growth factor granulin interacts with cyclin T1 and modulates P-TEFb-dependent transcription.

Authors:  Mainul Hoque; Tara M Young; Chee-Gun Lee; Ginette Serrero; Michael B Mathews; Tsafi Pe'ery
Journal:  Mol Cell Biol       Date:  2003-03       Impact factor: 4.272

6.  Transforming acidic coiled-coil protein-3 (Tacc3) acts as a negative regulator of Notch signaling through binding to CDC10/Ankyrin repeats.

Authors:  Sharon Bargo; Ahmed Raafat; David McCurdy; Idean Amirjazil; Youmin Shu; June Traicoff; Joshua Plant; Barbara K Vonderhaar; Robert Callahan
Journal:  Biochem Biophys Res Commun       Date:  2010-09-06       Impact factor: 3.575

7.  Progranulin (granulin/epithelin precursor) and its constituent granulin repeats repress transcription from cellular promoters.

Authors:  Mainul Hoque; Michael B Mathews; Tsafi Pe'ery
Journal:  J Cell Physiol       Date:  2010-04       Impact factor: 6.384

8.  A new procedure for determining the genetic basis of a physiological process in a non-model species, illustrated by cold induced angiogenesis in the carp.

Authors:  John M J Herbert; Francesca M Buffa; Henrik Vorschmitt; Stuart Egginton; Roy Bicknell
Journal:  BMC Genomics       Date:  2009-10-23       Impact factor: 3.969

Review 9.  Progranulin (granulin-epithelin precursor, PC-cell-derived growth factor, acrogranin) mediates tissue repair and tumorigenesis.

Authors:  Zhiheng He; Andrew Bateman
Journal:  J Mol Med (Berl)       Date:  2003-08-19       Impact factor: 4.599

Review 10.  Insights into the role of progranulin in immunity, infection, and inflammation.

Authors:  Jinlong Jian; Jessica Konopka; Chuanju Liu
Journal:  J Leukoc Biol       Date:  2012-10-22       Impact factor: 4.962

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.